ALYSSA RAMIREZ: Open Payments
NPI 1215451430 · FORT WORTH, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$201 in 9 payments from 6 companies in 2025. Trend: 2023 $298 · 2024 $601 · 2025 $201
Food & beverage: $201
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 3 | $52 |
| ABBVIE INC. | 2 | $44 |
| Neurocrine BioSciences, Inc. | 1 | $33 |
| Vanda Pharmaceuticals Inc. | 1 | $29 |
| Janssen Pharmaceuticals, Inc | 1 | $23 |
| Alkermes, Inc. | 1 | $20 |
Products named: VRAYLAR, INGREZZA, REXULTI, FANAPT, INVEGA SUSTENNA, ABILIFY ASIMTUFII, ARISTADA.
Industry payments across TX — which companies pay providers there.
